Search Results 971-980 of 15536 for fecal microbiota transplant

1. A Study of a Wearable Vital Signs Monitoring Device for the Detection of Systemic Inflammatory Response Syndrome and Sepsis in Stem Cell Transplant Patients - Mayo Clinic

   A Study of a Wearable Vital Signs Monitoring Device for the Detection of Systemic Inflammatory Response Syndrome and Sepsis in Stem Cell Transplant Patients.

2. Publications - Shennen A. Mao, M.D. - Mayo Clinic

   Croome KP, Subramanian V, Mathur AK, Aqel B, Mao SA, Clendenon JN, Perry DK, Dhanireddy K, Taner CB. Outcomes of DCD Liver Transplant Using Sequential ...

3. Mayo Clinic Q&A podcast: COVID-19 lung damage could lead to a transplant

   "As we know, lungs are one of the major organs that are involved with COVID infection," says Dr. Sadia Shah, a Mayo Clinic transplant pulmonologist and critical ...

4. A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT) - Mayo Clinic

   About this study. The purpose of the study is to determine if overall mortality is affected one year after a hematopoietic stem cell transplant (HCT) in ...

5. Mayo Clinic Study Suggests Acute Injured Kidneys can be considered for Transplant

   Deceased donors with AKI whose kidney function was diminished were studied, with 70 percent classified as having severe AKI. Researchers found that transplant ...

6. Innovative transplants offer hope for patients with rare autoimmune disorder - Mayo Clinic News Network

   As a career military man, Chris Ryals was used to being physically active. The Air Force master sergeant regularly ran, visited the gym and lifted weights.

7. A Study of the Quantiferon CMV Blood Test to Predict the Risk of CMV Returning After Treatment of the Disease in Solid Organ Transplant Recipients - Mayo Clinic

   The overall aim of this study is to determine whether solid organ transplant recipients who develop immunity to cytomegalovirus (CMV) after an initial episode ...

8. Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) - Mayo Clinic

   Acute Graft-versus-Host-Disease (GVHD) is an important cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). This ...

9. Extension Trial on Efficacy /​ Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3) (BOSTON-3) - Mayo Clinic

   Extension Trial on Efficacy /​ Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3) (BOSTON-3) · Overview · Participation ...

10. Respiratory complications of hematopoietic stem cell transplantation - Mayo Clinic

    Hematopoietic stem cell transplantation (HCT) is a potentially curative and lifesaving treatment option for hematologic cancers such as leukemia, ...